期刊文献+

输注调节性T细胞延缓非肥胖糖尿病小鼠糖尿病的发生 被引量:5

Infusion of regulatory T cells delayed the development of autoimmune diabetes in non-obese diabetic mice
原文传递
导出
摘要 目的观察过继输注调节性T细胞(Treg)对非肥胖糖尿病(NOD)小鼠自发性糖尿病发生的影响。方法分选NOD小鼠天然调节性T细胞(nTreg),并诱导Naive T细胞转化为CD4^+CD25^+ Foxp3^+调节性T细胞(iTreg),分别输注予4周龄的雌性NOD小鼠,观察糖尿病的发生情况,并确定细胞输注后Treg在体内的分布、检测血清中TGF-β1、IL-10及IL-4的表达以探讨Treg的作用机制。结果对照组小鼠13周龄时即100%自发性发生糖尿病,而输注iTreg和nTreg分别能延缓糖尿病的发生时间至24周龄和25周龄,与对照组比较差异有统计学意义(P〉0.05)。Treg细胞输注后主要分布在胸腺,iTreg在体内能促进TGF-β1、IL-10及IL-4表达的上调[血中浓度分别为(543.00±26.51)、(107.67±12.66)、(93.33±12.58)ng/L],与对照组比较差异有统计学意义[(60.67±15.82)、(20.67±6.03)、(30.67±5.51)ng/L,P〈0.05]。结论在体外诱导生成的调节性T细胞可延缓NOD小鼠糖尿病的发生,其机制与上调具有免疫抑制效应的细胞因子相关。 Objective To investigate the effects on the development of autoimmune diabetes by infusing regulatory T cells (Treg cells) in non-obese diabetic (NOD) mice. Methods Natural Treg cells (nTreg) were isolated and Naive T cells were induced into CD4^+ CD25^+ Foxp3^+ Treg cells (iTreg). nT- leg and iTreg cells were infused into 4-week-old female mice respectively. The development of autoimmune diabetes,distribution of Treg ceils in the NOD mice after infusion, and the serum level of transforming growth factor-β1 ( TGF-β1 ) , intedeukin-10 (IL-10) and interleukin-4 ( IL-4 ) were observed. Results The mice infused with nTreg or iTreg cells developed autoimmune diabetes at 24 or 25 weeks old respec- tively. The time of autoimmune diatetes development was significantly delayed in nTreg or iTreg cells treated mice as compared with the untreated NOD mice (P 〈0.05 ) which developed autoimmune diabetes at 13 weeks old. Treg cells were distributed into thymus after being infused into NOD mice. The euncentra- tions of TGFo[31 ,IL-10 and IL-4 in iTreg cells treated mice were (543.00 ±26.51 ), ( 107.67 ± 12.66) and (93.33 ± 12.58) ng/L,which were significantly upreguated as compared with those in untreated mice ( P 〈 0.05 ), which were ( 60.67 ± 15.82 ), ( 20.67 ± 6.03 ) and ( 30.67 ± 5.51 ) ng/Lm, respectively. Conclusion Infusion of the Treg cells can delay the development of autoimmune diabetes in NOD mice by up-regulating, the expression of TGF-β1 .IL-10 and IL-4.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第5期574-576,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30671002)
关键词 调节性T细胞 糖尿病 自身免疫性 Regulatory T cells Diabetes Autoimmune
  • 相关文献

参考文献2

二级参考文献11

  • 1周军,汪建平,兰平,吴小剑,黄美近,宋新明.结肠抗原特异性T细胞克隆回输治疗大鼠溃疡性结肠炎的研究[J].中华实验外科杂志,2004,21(10):1206-1208. 被引量:14
  • 2张弘炜,史留斌,彭承宏.CD4^+CD25^+T细胞联合CD154单抗抑制大鼠肝移植急性排斥反应的研究[J].中华实验外科杂志,2007,24(2):196-198. 被引量:8
  • 3Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol,2005 ,23 :447-485.
  • 4Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nature Rev Immunol,2003 ,3 :253-257.
  • 5Chen W,Jin W,Hardegen N,et al. Conversion of peripheral CD4^+ CD25^ - Naive T cells to CD4^+ CD25^+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med,2003,198 : 1875- 1886.
  • 6Thornton AM, Donovan EE, Piccirillo CA, et al. Cutting edge: IL-2 is critically required for the in vitro activation of CD4^+ CD25^+ T cell suppressor function. J Immunol,2004,172:6519-6523.
  • 7Masteller EL,Warner MR,Tang Q,et al. Expansion of functional endogenous antigen-specific CD4^+ CD25^+ regulatory T cells from nonobese diabetic mice. J Immunol,2005 175:3053-3059.
  • 8Schwartz RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med, 1996,184 : 1-8.
  • 9Song GZ,Ju HW,William S,et al. TGF-β Requires CTIA-4 early after T Cell Activation to Induce Foxp3 and generate Adaptive CD4^+ CD25^ + regulatory cells1. J Immunol,2006 ,176 :3321-3329.
  • 10Jaeckel E, Boehmer H, Manns MP. Antigen-specific Foxp3-transduced T-cells can control established type 1 diabetes. Diabetes, 2005,54: 306-310.

共引文献1

同被引文献83

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部